Extracorporeal Magnetic Innervation in Combination With Mirabegron in the Treatment of Overactive Bladder

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

October 14, 2019

Primary Completion Date

April 3, 2023

Study Completion Date

October 1, 2023

Conditions
Overactive BladderOveractive Bladder Syndrome
Interventions
DRUG

mirabegron 50 mg daily

Patients in both study groups will receive 50 mg of mirabegron daily in the form of tablets, which is used to treat OAB according to current treatment guidelines.

DEVICE

Extracorporeal magnetic innervation (active treatment)

Patients will twice a week receive extracorporeal electromagnetic stimulation in the duration of 20 minutes. Patients will be randomized into 2 study groups, namely one group will receive actual electromagnetic stimulation, and the other group will receive sham stimulation.

DEVICE

Extracorporeal magnetic innervation (sham treatment)

Patients will twice a week receive extracorporeal electromagnetic stimulation in the duration of 20 minutes. Patients will be randomized into 2 study groups, namely one group will receive actual electromagnetic stimulation, and the other group will receive placebo stimulation.

Trial Locations (1)

2000

University Medical Centre Maribor, Maribor

All Listed Sponsors
lead

Serdinsek Tamara

OTHER

NCT06123364 - Extracorporeal Magnetic Innervation in Combination With Mirabegron in the Treatment of Overactive Bladder | Biotech Hunter | Biotech Hunter